P664 SB5 and reference adalimumab show cross-immunogenicity...

P664 SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis

Gonçalves, J, Myung, G, Hong, E, Park, M, Jeong, D, Ghil, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.788
Date:
January, 2019
File:
PDF, 284 KB
english, 2019
Conversion to is in progress
Conversion to is failed